Entering text into the input field will update the search result below

FDA OKs Axonics' wireless patient remote control with SmartMRI technology

Jun. 03, 2020 6:21 AM ETAxonics, Inc. (AXNX) StockBy: SA News Team
  • Under a premarket approval supplement, the FDA has approved Axonics Modulation Technologies' (NASDAQ:AXNX) new wireless patient Remote Control with SmartMRI technology for the Axonics r-SNM System.
  • The new Remote Control simplifies the process by which patients can receive a full-body MRI.
  • The new patient Remote Control will be included in all new orders of the Axonics r-SNM System in the U.S. beginning this month.

Recommended For You

More Trending News

About AXNX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AXNX--
Axonics, Inc.